Barbet J - Search Results

1

Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.

Vuillez JP, Moro D, Brichon PY, Rouvier E, Brambilla E, Barbet J, Peltier P, Meyer P, Sarrazin R, Brambilla C. Vuillez JP, et al. Among authors: barbet j. J Nucl Med. 1997 Apr;38(4):507-11. J Nucl Med. 1997. PMID: 9098191 Free article.

2

Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.

Kraeber-Bodéré F, Rousseau C, Bodet-Milin C, Ferrer L, Faivre-Chauvet A, Campion L, Vuillez JP, Devillers A, Chang CH, Goldenberg DM, Chatal JF, Barbet J. Kraeber-Bodéré F, et al. Among authors: barbet j. J Nucl Med. 2006 Feb;47(2):247-55. J Nucl Med. 2006. PMID: 16455630 Free article. Clinical Trial.

3

Pretargetted imaging of colorectal cancer recurrences using an 111In-labelled bivalent hapten and a bispecific antibody conjugate.

Chetanneau A, Barbet J, Peltier P, Le Doussal JM, Gruaz-Guyon A, Bernard AM, Resche I, Rouvier E, Bourguet P, Delaage M, et al. Chetanneau A, et al. Among authors: barbet j. Nucl Med Commun. 1994 Dec;15(12):972-80. doi: 10.1097/00006231-199412000-00009. Nucl Med Commun. 1994. PMID: 7715897

4

Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.

Peltier P, Curtet C, Chatal JF, Le Doussal JM, Daniel G, Aillet G, Gruaz-Guyon A, Barbet J, Delaage M. Peltier P, et al. Among authors: barbet j. J Nucl Med. 1993 Aug;34(8):1267-73. J Nucl Med. 1993. PMID: 8326383 Free article.

5

Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancer.

Bardiès M, Bardet S, Faivre-Chauvet A, Peltier P, Douillard JY, Mahé M, Fiche M, Lisbona A, Giacalone F, Meyer P, Gautherot E, Rouvier E, Barbet J, Chatal JF. Bardiès M, et al. Among authors: barbet j. J Nucl Med. 1996 Nov;37(11):1853-9. J Nucl Med. 1996. PMID: 8917192 Free article.

6

Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.

Barbet J, Peltier P, Bardet S, Vuillez JP, Bachelot I, Denet S, Olivier P, Leccia F, Corcuff B, Huglo D, Proye C, Rouvier E, Meyer P, Chatal JF. Barbet J, et al. J Nucl Med. 1998 Jul;39(7):1172-8. J Nucl Med. 1998. PMID: 9669389 Free article. Clinical Trial.

7

Delivery of therapeutic doses of radioiodine using bispecific antibody-targeted bivalent haptens.

Gautherot E, Le Doussal JM, Bouhou J, Manetti C, Martin M, Rouvier E, Barbet J. Gautherot E, et al. Among authors: barbet j. J Nucl Med. 1998 Nov;39(11):1937-43. J Nucl Med. 1998. PMID: 9829586 Free article.

8

Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: results of a phase I/II trial.

Vuillez JP, Kraeber-Bodéré F, Moro D, Bardiès M, Douillard JY, Gautherot E, Rouvier E, Barbet J, Garban F, Moreau P, Chatal JF. Vuillez JP, et al. Among authors: barbet j. Clin Cancer Res. 1999 Oct;5(10 Suppl):3259s-3267s. Clin Cancer Res. 1999. PMID: 10541373 Clinical Trial.

9

Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten.

Gautherot E, Rouvier E, Daniel L, Loucif E, Bouhou J, Manetti C, Martin M, Le Doussal JM, Barbet J. Gautherot E, et al. Among authors: barbet j. J Nucl Med. 2000 Mar;41(3):480-7. J Nucl Med. 2000. PMID: 10716323 Free article.

10

Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.

Salaun PY, Campion L, Bournaud C, Faivre-Chauvet A, Vuillez JP, Taieb D, Ansquer C, Rousseau C, Borson-Chazot F, Bardet S, Oudoux A, Cariou B, Mirallié E, Chang CH, Sharkey RM, Goldenberg DM, Chatal JF, Barbet J, Kraeber-Bodéré F. Salaun PY, et al. Among authors: barbet j. J Nucl Med. 2012 Aug;53(8):1185-92. doi: 10.2967/jnumed.111.101865. Epub 2012 Jun 28. J Nucl Med. 2012. PMID: 22743249 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

321 results

Search Page

Filters